Search clinical trials for: PARP inhibitor BMN-673
Total 1900 results
-
National Cancer Institute (NCI)CompletedRecurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma | Recurrent Adult Lymphoblastic Lymphoma | Recurrent Grade 1 Follicular Lymphoma | Recurrent Grade 2 Follicular Lymphoma and other conditionsUnited States
-
Fenway Community HealthCompleted
-
AstraZenecaCompleted
-
Bristol-Myers SquibbCompleted
-
National Cancer Institute (NCI)CompletedRecurrent Salivary Gland Carcinoma | Salivary Gland Adenoid Cystic Carcinoma | Stage IV Major Salivary Gland Cancer AJCC v7 | Malignant Salivary Gland NeoplasmUnited States, Canada
-
CTI BioPharmaPPDCompletedDrug InteractionsUnited States
-
Hoffmann-La RocheCompletedHIV InfectionsUnited States
-
Bristol-Myers SquibbCompleted
-
Bristol-Myers SquibbCompletedHealthy VolunteersUnited Kingdom
-
Radboud University Medical CenterBristol-Myers SquibbActive, not recruitingProstatic Neoplasms, Castration-ResistantNetherlands
-
Kristen GanjooBristol-Myers SquibbCompletedSoft Tissue SarcomaUnited States
-
ExelixisActive, not recruitingRenal Cell CarcinomaUnited States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, Czechia, Finland, France, Germany, Hong Kong, Hungary, Israel, Italy, Korea, Republic of, Mexico, Netherlands, New Zealand, Poland, Singapore, Spain, Taiwan, United...
-
IRCCS Azienda Ospedaliera Universitaria San Martino...UnknownNon Small Cell Lung CancerItaly
-
AIO-Studien-gGmbHAstraZenecaTerminatedNSCLC | Non-squamous Non-small Cell Lung Cancer Stage II | Non-squamous Non-small Cell Lung Cancer Stage IIIA | Non-squamous Non-small Cell Lung Cancer Stage IIIB | Activating EGFR MutationGermany
-
Bristol-Myers SquibbCompleted
-
National Cancer Institute (NCI)CompletedNeuroendocrine Carcinoma | Small Cell Carcinoma | Extensive Stage Small Cell Lung Carcinoma | Stage IV Non-Small Cell Lung Cancer AJCC v7 | Large Cell Lung CarcinomaUnited States
-
National Cancer Institute (NCI)Terminated
-
Bristol-Myers SquibbActive, not recruitingAdvanced CancerUnited States, Spain, Argentina, Belgium, Korea, Republic of, Japan
-
Bristol-Myers SquibbNovartis; Clovis Oncology, Inc.; Janssen Pharmaceuticals; ExelixisRecruitingCancerUnited States, Israel, Spain, Italy, Germany, Australia, Belgium, China, Korea, Republic of, Greece, Japan, Argentina, Austria, Brazil, Canada, Chile, Denmark, Finland, France, Hungary, Ireland, Mexico, Netherlands, Poland, Russian Federation and more
-
Novartis PharmaceuticalsCompleted
-
Bristol-Myers SquibbPfizerCompletedNonValvular Atrial FibrillationJapan
-
Bristol-Myers SquibbPfizerCompleted
-
Bristol-Myers SquibbPfizerTerminatedVenous ThromboembolismUnited States, Belgium, Canada, Mexico, Netherlands
-
Massachusetts General HospitalActive, not recruiting
-
IWK Health CentreHoffmann-La Roche; Nova Scotia Health Authority; Dalhousie University; Canadian...Completed
-
Bristol-Myers SquibbPfizerCompletedVenous ThrombosisArgentina, Australia, Canada, China, Czech Republic, India, Italy, Korea, Republic of, United States, Spain, France, Brazil, Russian Federation, Mexico, Austria, Denmark, Germany, Hungary, Israel, Portugal, Romania, Singapore, Norway, Chil... and more
-
Bristol-Myers SquibbZai Lab (Shanghai) Co., Ltd.RecruitingCarcinoma, Non-Small-Cell LungJapan, China, Canada, Spain, Germany, Korea, Republic of, Austria, Brazil, Greece, France, United States, Italy, Argentina, Chile, Hungary, India, Turkey, Romania, Netherlands, Poland, Switzerland
-
Bristol-Myers SquibbActive, not recruiting
-
Astellas Pharma IncCompletedArthritis, RheumatoidJapan
-
Cinclus Pharma Holding ABCompletedPharmacokinetics | Safety Issues | Tolerability | Drug InteractionSweden
-
Global Alliance for TB Drug DevelopmentCompleted
-
University of Medicine and Dentistry of New JerseyNational Cancer Institute (NCI)TerminatedBreast CancerUnited States
-
Eli Lilly and CompanyNew Approaches to Neuroblastoma Therapy Consortium (NANT); Innovative Therapies...Active, not recruitingNeuroblastomaUnited States, Spain, Australia, Belgium, Japan, France, Germany, Italy, United Kingdom
-
Zydus Therapeutics Inc.Completed
-
National Cancer Institute, NaplesCompleted
-
University of UlmCAPNETZ StiftungTerminated
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary Disease | Healthy VolunteersUnited States
-
Rutgers, The State University of New JerseyNational Cancer Institute (NCI)CompletedLymphoma | Metastatic Melanoma | Metastatic Renal Cell Cancer | Recurrent Renal Cell Carcinoma | Stage III Renal Cell Cancer | Stage IV Skin Melanoma | Stage IIIB Skin Melanoma | Stage IIIC Skin Melanoma | Stage III Bladder Cancer | Stage IV Bladder Cancer | Recurrent Lymphoma | Recurrent Malignant Solid Neoplasm and other conditionsUnited States
-
Beth Israel Deaconess Medical CenterBristol-Myers SquibbRecruitingHidradenitis SuppurativaUnited States
-
University of California, IrvineBristol-Myers SquibbCompletedRecurrent Prostate Cancer | Prostate Cancer | Hormone-resistant Prostate Cancer | Adenocarcinoma of the Prostate | Hormone-refractory Prostate CancerUnited States
-
M.D. Anderson Cancer CenterBristol-Myers SquibbTerminated
-
Gynecologic Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Fallopian Tube Carcinoma | Recurrent Ovarian Carcinoma | Recurrent Primary Peritoneal CarcinomaUnited States
-
Bristol-Myers SquibbCompletedNon Small Cell Lung CancerKorea, Republic of, Taiwan, United States, Spain, France, Argentina, Canada, Poland
-
Bristol-Myers SquibbCompletedSclerodermaUnited States
-
Bristol-Myers SquibbCompleted
-
National Cancer Institute (NCI)TerminatedAdvanced Adult Primary Liver Cancer | Recurrent Adult Primary Liver Cancer | Adult Primary Hepatocellular CarcinomaUnited States
-
Otsuka Pharmaceutical Development & Commercialization...CompletedPancreatic CancerBelgium, Canada, France, Russian Federation, Italy, United States, Australia, Austria, Germany, Romania, Hungary, Poland, United Kingdom, Ireland, Czech Republic
-
National Cancer Institute (NCI)CompletedSquamous Cell Carcinoma of the Skin | Recurrent Skin Cancer | Stage 0 Chronic Lymphocytic Leukemia | Stage I Chronic Lymphocytic LeukemiaUnited States
-
Bristol-Myers SquibbCompletedBreast Cancer | MetastasisUnited States, Spain, Belgium, Peru, Italy, Argentina, France
-
CelgeneNot yet recruitingHealthy ParticipantsUnited States